The importance of examining the proportion of circulating DNA originating from tumor, microenvironment and normal cells in colorectal cancer patients

Quantitative Detection of EGFR Mutations in Circulating Tumor DNA Derived from Lung Adenocarcinomas

(2011) K. Taniguchi et al.   CLINICAL CANCER RESEARCH

High Fragmentation Characterizes Tumour-Derived Circulating DNA

(2011) Florent Mouliere et al.   PLoS One

The proportion of tumour cells is an independent predictor for survival in colorectal cancer patients

(2010) N P West et al.   BRITISH JOURNAL OF CANCER

The virtosome-a novel cytosolic informative entity and intercellular messenger

(2010) Peter B. Gahan et al.   CELL BIOCHEMISTRY AND FUNCTION

Cell-free DNA in the blood as a solid tumor biomarker—A critical appraisal of the literature

(2010) Klaus Jung et al.   CLINICA CHIMICA ACTA

Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts

(2010) Alain R. Thierry et al.   NUCLEIC ACIDS RESEARCH

Development of Personalized Tumor Biomarkers Using Massively Parallel Sequencing

(2010) R. J. Leary et al.   Science Translational Medicine

Lipoplex nanostructures reveal a general self-organization of nucleic acids

(2009) Alain R. Thierry et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Analysis of Circulating Tumor DNA to Confirm Somatic KRAS Mutations

(2009) Matthias Holdhoff et al.   JNCI-Journal of the National Cancer Institute

Mutation Detection by Real-Time PCR: A Simple, Robust and Highly Selective Method

(2009) John Morlan et al.   PLoS One

Quantitative and qualitative characterization of plasma DNA identifies primary and recurrent colorectal cancer

(2008) M. Frattini et al.   CANCER LETTERS

Size distribution of circulating cell-free DNA in sera of breast cancer patients in the course of adjuvant chemotherapy

(2008) Ugur Deligezer et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Circulating mutant DNA to assess tumor dynamics

(2008) Frank Diehl et al.   NATURE MEDICINE